Trial Profile
A Study to Evaluate the Factors Related to the Successful Outcome of OK-432 Sclerotherapy in Patients with Lymphatic Malformations in the Head and Neck
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Picibanil (Primary)
- Indications Lymphangioma
- Focus Therapeutic Use
- 24 Dec 2015 New trial record